Tag: research

MSD and Themis Bioscience Announce Research Collaboration Agreement

research
Themis Bioscience announced a research collaboration and exclusive license agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) for the discovery and development of undisclos...

CureVac AG Announced Collaborative Research Agreement with Yale University

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced it has entered into a Collaborative Research Agreement with Yale University for discovery r...

BI & MD Anderson Form Research and Development Center

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center(link is external) announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for v...

AC Immune and University of Pennsylvania Announce Research Collaboration

AC Immune SA, a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced a research partnership with leading scientists in the...

Yokohama City University, Tokyo University of Arts and Astellas Announce Launch of Health Mock Lab

astellas
Yokohama City University, Tokyo University of the Arts and Astellas Pharma Inc. announced that they have launched “Health Mock Lab.” as a virtual framework for industry-academia collaboration aimed at...

Sosei & Takeda to Develop Novel Molecules

takeda
Sosei Group Corporation announces that it has entered into a strategic multi-target partnership with Takeda Pharmaceutical Company Limited, to discover, develop and commercialize novel molecules, incl...

FDA Signed New Agreement with NIIMBL to Strengthen Innovation in Biopharmacy

research
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Develop...

MediciNova Announced Collaboration with the Japanese Research Center

research
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that it will initiate a comprehensive research collaborati...

Intensity Therapeutics and Merck Agreed to Conduct Clinical Research

Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary therapeutic agen...

Servier Laid Foundation Stone of its Future Research Institute

Servier, an independent international pharmaceutical company, has laid the foundation stone of its future Research Institute in the Paris-Saclay cluster. The new Servier Paris-Saclay Research Institut...

Harbour BioMed, Erasmus MC Sign Memorandum to Develop Next-Generation Biotherapeutics

Harbour BioMed (HBM) and Erasmus MC, University Medical Center Rotterdam announced that they have signed a 10-year Memorandum of Understanding (MOU) to enable a broad range of joint basic, translation...

Siberian and Mongolian Researchers to Develop New Methods of Theranostics

Siberian and Mongolian researchers have teamed up to develop new methods of theranostics – a combination of specific targeted therapy and specific targeted diagnostic tests – for treating difficult-to...

BI to Set Up First Industry-Academia-Research Exchange Platform

Boehringer Ingelheim and Harbin Veterinary Research Institute (HVRI), subordinated to the Chinese Academy of Agricultural Sciences (CAAS), jointly unveiled the first ‘industry-academia-research’ excha...

Harvard-led Research Boosts Cell Therapy for Diabetes

diabetes drugs
A team of researchers led by Harvard University scientists has improved the laboratory process of converting stem cells into insulin-producing beta cells, using biological and physical separation meth...

Sanofi and Alnylam Agreed to Conclude and Option Phase of 2014 RNAi Therapeutics Collaboration

Sanofi and Alnylam have agreed to conclude the research and option phase of the companies' 2014 RNAi therapeutics alliance in rare genetic diseases. The material collaboration terms for patisiran, vut...

CDER Offers New Approach to Evaluate Fentanyl Meds Safety

As fentanyl analogs present a major risk to public health, and as these analogs can evade prosecution, the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has de...